Phase 3 Liver Transplant Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR Trial)
Acute Kidney Injury Post Liver Transplantation
Assistance Publique - Hôpitaux de Paris304 enrolled1 locationNCT06344442
Recruiting
Phase 3
Darbepoetin in Patients Candidates for Liver Transplant. (EPO-LT Trial)
Liver Transplant; Complications
Fundacion Clinic per a la Recerca Biomédica140 enrolled1 locationNCT07169643
Recruiting
Phase 2Phase 3
Effect of TCI Propofol on Liver Transplant (TCI) Propofol on Intra-operative Usage of Vasopressors in Liver Transplant Recipients.
Liver Transplant Recipients
Institute of Liver and Biliary Sciences, India60 enrolled1 locationNCT06418893
Recruiting
Phase 3
Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver Transplantation
Hepatocellular CarcinomaLiver Transplantation
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School40 enrolled1 locationNCT04595864